Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Neuro-Oncology · 05.01.2023 · 25 (1) · 4-25
DOI: 10.1093/neuonc/noac207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 12.10.2022. Verfasst von Julie J Miller und 30 weiteren Autor:innen. Beteiligte Einrichtung: Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms. Die Arbeit wurde bisher 250-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant primary brain tumors diagnosed in patients younger than 50, constituting an important cause of morbidity and mortality. In recent years, there has been significant progress in understanding the molecular pathogenesis and biology of these tumors, sparking multiple efforts to improve their diagnosis and treatment. In this consensus review from the Society for Neuro-Oncology (SNO), the current diagnosis and management of IDH-mutant gliomas will be discussed. In addition, novel therapies, such as targeted molecular therapies and immunotherapies, will be reviewed. Current challenges and future directions for research will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
- Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas, 75235, USA.
- Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.
ORCID-Profile: L Nicolas Gonzalez Castro, Michael Weller, Mitchell S Berger, Ranjit Bindra, Daniel P Cahill, Craig Horbinski, Robert B Jenkins, Wolfgang Wick
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Miller, J. J., Gonzalez Castro, L. N., McBrayer, S., Weller, M., Cloughesy, T., Portnow, J., Andronesi, O., Barnholtz-Sloan, J. S., Baumert, B. G., Berger, M. S., Bi, W. L., Bindra, R., Cahill, D. P., Chang, S. M., Costello, J. F., Horbinski, C., Huang, R. Y., Jenkins, R. B., Ligon, K. L., …, & Wen, P. Y. (2023). Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology, 25(1), 4-25. https://doi.org/10.1093/neuonc/noac207
Vancouver
Miller JJ, Gonzalez Castro LN, McBrayer S, Weller M, Cloughesy T, Portnow J, et al. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Neuro-Oncology. 2023;25(1):4-25. doi:10.1093/neuonc/noac207
BibTeX
@article{Miller2023,
author = {Miller, Julie J and Gonzalez Castro, L Nicolas and McBrayer, Samuel and Weller, Michael and Cloughesy, Timothy and Portnow, Jana and Andronesi, Ovidiu and Barnholtz-Sloan, Jill S and Baumert, Brigitta G and Berger, Mitchell S and Bi, Wenya Linda and Bindra, Ranjit and Cahill, Daniel P and Chang, Susan M and Costello, Joseph F and Horbinski, Craig and Huang, Raymond Y and Jenkins, Robert B and Ligon, Keith L and Mellinghoff, Ingo K and Nabors, L Burt and Platten, Michael and Reardon, David A and Shi, Diana D and Schiff, David and Wick, Wolfgang and Yan, Hai and von Deimling, Andreas and van den Bent, Martin and Kaelin, William G and Wen, Patrick Y},
title = {Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {1},
pages = {4--25},
doi = {10.1093/neuonc/noac207}
}
EUVIMED